North Star Asset Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.89M | Sell |
83,963
-940
| -1% | -$131K | 0.43% | 74 |
|
|
2025
Q4 | $13.9M | Sell |
84,903
-536
| -0.6% | -$84K | 0.56% | 56 |
|
|
2025
Q3 | $11.4M | Sell |
85,439
-2,163
| -2% | -$263K | 0.46% | 69 |
|
|
2025
Q2 | $10.9M | Sell |
87,602
-2,191
| -2% | -$279K | 0.46% | 73 |
|
|
2025
Q1 | $11.4M | Sell |
89,793
-334
| -0.4% | -$51.4K | 0.52% | 60 |
|
|
2024
Q4 | $13M | Sell |
90,127
-2,003
| -2% | -$287K | 0.57% | 60 |
|
|
2024
Q3 | $13.7M | Sell |
92,130
-1,594
| -2% | -$229K | 0.62% | 58 |
|
|
2024
Q2 | $11.8M | Buy |
93,724
+1,518
| +2% | +$238K | 0.56% | 61 |
|
|
2024
Q1 | $17M | Buy |
92,206
+550
| +0.6% | +$105K | 0.8% | 43 |
|
|
2023
Q4 | $16.5M | Sell |
91,656
-41
| -0% | -$6.38K | 0.84% | 41 |
|
|
2023
Q3 | $14.6M | Buy |
91,697
+375
| +0.4% | +$61.3K | 0.84% | 40 |
|
|
2023
Q2 | $12.9M | Buy |
91,322
+2,326
| +3% | +$373K | 0.71% | 48 |
|
|
2023
Q1 | $15M | Buy |
88,996
+1,916
| +2% | +$342K | 0.88% | 42 |
|
|
2022
Q4 | $14.7M | Buy |
87,080
+2,544
| +3% | +$461K | 0.92% | 39 |
|
|
2022
Q3 | $15.8M | Buy |
84,536
+1,413
| +2% | +$298K | 1.08% | 34 |
|
|
2022
Q2 | $13.5M | Buy |
83,123
+435
| +0.5% | +$68.8K | 0.89% | 43 |
|
|
2022
Q1 | $15.6M | Buy |
82,688
+1,145
| +1% | +$218K | 0.86% | 40 |
|
|
2021
Q4 | $21.6M | Sell |
81,543
-1,998
| -2% | -$538K | 1.09% | 32 |
|
|
2021
Q3 | $24.1M | Sell |
83,541
-6,082
| -7% | -$1.56M | 1.33% | 25 |
|
|
2021
Q2 | $17.9M | Sell |
89,623
-842
| -0.9% | -$163K | 0.99% | 34 |
|
|
2021
Q1 | $17.6M | Sell |
90,465
-5,640
| -6% | -$1.16M | 1.05% | 32 |
|
|
2020
Q4 | $18.4M | Sell |
96,105
-2,628
| -3% | -$478K | 1.16% | 28 |
|
|
2020
Q3 | $14.6M | Sell |
98,733
-8,272
| -8% | -$1.18M | 1.07% | 34 |
|
|
2020
Q2 | $13.2M | Sell |
107,005
-17,494
| -14% | -$2.06M | 1.05% | 35 |
|
|
2020
Q1 | $12M | Sell |
124,499
-5,870
| -5% | -$567K | 1.16% | 28 |
|
|
2019
Q4 | $12.1M | Sell |
130,369
-3,736
| -3% | -$314K | 0.87% | 41 |
|
|
2019
Q3 | $10.3M | Sell |
134,105
-9,849
| -7% | -$861K | 0.81% | 43 |
|
|
2019
Q2 | $12.4M | Sell |
143,954
-3,530
| -2% | -$241K | 0.97% | 37 |
|
|
2019
Q1 | $8.71M | Buy |
147,484
+2,140
| +1% | +$123K | 0.71% | 51 |
|
|
2018
Q4 | $7.67M | Sell |
145,344
-4,847
| -3% | -$284K | 0.73% | 50 |
|
|
2018
Q3 | $8.33M | Sell |
150,191
-20,794
| -12% | -$1.07M | 0.67% | 56 |
|
|
2018
Q2 | $8.04M | Sell |
170,985
-290
| -0.2% | -$11.9K | 0.69% | 54 |
|
|
2018
Q1 | $6.2M | Buy |
171,275
+61,630
| +56% | +$2.17M | 0.56% | 67 |
|
|
2017
Q4 | $3.98M | Buy |
109,645
+84,486
| +336% | +$3.06M | 0.36% | 83 |
|
|
2017
Q3 | $964K | Buy |
25,159
+4,610
| +22% | +$193K | 0.1% | 149 |
|
|
2017
Q2 | $852K | Buy |
20,549
+5,040
| +32% | +$192K | 0.09% | 156 |
|
|
2017
Q1 | $546K | Buy |
+15,509
| New | +$491K | 0.06% | 167 |
|
Other funds holding RGEN
UCFA
VCM
VPM
MC
North Star Asset Management's RGEN Position: Q1 2026 in Review
North Star Asset Management reduced its Repligen (RGEN) stake by 1.1% in Q1 2026, selling an estimated $131K and leaving 83,963 shares worth $9.89M. The position accounts for 0.43% of the portfolio, ranked #74.
North Star Asset Management first reported a position in RGEN in Q1 2017 and has held it in 37 quarters since. The position peaked at $24.1M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- North Star Asset Management held 83,963 shares of Repligen worth $9.89M as of Q1 2026.
- North Star Asset Management sold 940 Repligen shares in Q1 2026, an estimated $131K.
- Repligen made up 0.43% of North Star Asset Management's portfolio in Q1 2026, its #74 holding.
- North Star Asset Management first reported a position in Repligen in Q1 2017 and has held it in 37 quarters since.
- North Star Asset Management's Repligen position peaked at $24.1M in Q3 2021.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on North Star Asset Management's 13F filing for Q1 2026, filed 6 May 2026.